ACM

ADAR1 Capital Management Portfolio holdings

AUM $1.34B
1-Year Est. Return 288.83%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+288.83%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.34B
AUM Growth
+$327M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
284
New
Increased
Reduced
Closed

Top Buys

1 +$31.8M
2 +$14.2M
3 +$12.6M
4
TERN icon
Terns Pharmaceuticals
TERN
+$12.3M
5
ABUS icon
Arbutus Biopharma
ABUS
+$11.3M

Top Sells

1 +$94.2M
2 +$31.1M
3 +$15.5M
4
MTSR
Metsera Inc
MTSR
+$7.98M
5
IVVD icon
Invivyd
IVVD
+$7.22M

Sector Composition

1 Healthcare 90.32%
2 Financials 1.75%
3 Real Estate 0.13%
4 Communication Services 0.08%
5 Consumer Discretionary 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMVP icon
226
PMV Pharmaceuticals
PMVP
$95.8M
$126K 0.01%
101,008
GBIO
227
DELISTED
Generation Bio
GBIO
$126K 0.01%
22,144
NEUP
228
Neuphoria Therapeutics
NEUP
$22.9M
$116K 0.01%
+30,000
CLOV icon
229
Clover Health Investments
CLOV
$1.05B
$114K 0.01%
48,300
ZNTL icon
230
Zentalis Pharmaceuticals
ZNTL
$162M
$108K 0.01%
80,000
+30,000
BCAB icon
231
BioAtla
BCAB
$15.1M
$104K 0.01%
+183,107
SABS icon
232
SAB Biotherapeutics
SABS
$194M
$98.5K 0.01%
26,344
+11,344
KYNB
233
Kyntra Bio
KYNB
$28.5M
$91.9K 0.01%
+10,469
RZLT icon
234
Rezolute
RZLT
$300M
$91.3K 0.01%
38,679
-777,296
NMRA icon
235
Neumora Therapeutics
NMRA
$544M
$90.6K 0.01%
+50,600
PLRX icon
236
Pliant Therapeutics
PLRX
$78M
$90.1K 0.01%
+73,819
LITS
237
Lite Strategy Inc
LITS
$40.7M
$88.8K 0.01%
67,292
-225,105
IRD
238
Opus Genetics
IRD
$299M
$80.4K 0.01%
+40,000
KALA icon
239
KALA BIO
KALA
$354M
$78.6K 0.01%
141,480
-515
VERU icon
240
Veru
VERU
$42.1M
$74.9K 0.01%
+35,000
QTTB icon
241
Q32 Bio
QTTB
$60.9M
$66.4K 0.01%
+20,000
MREO
242
Mereo BioPharma
MREO
$63.3M
$62.5K ﹤0.01%
+150,000
BMEA icon
243
Biomea Fusion
BMEA
$96.9M
$53.8K ﹤0.01%
+43,420
ASPCR
244
A SPAC III Acquisition Corp Right
ASPCR
$40.9K ﹤0.01%
215,000
ATYR
245
aTyr Pharma
ATYR
$97M
$39.7K ﹤0.01%
50,685
-124,315
PRQR icon
246
ProQR Therapeutics
PRQR
$166M
$20.2K ﹤0.01%
10,000
IVF
247
INVO Fertility Inc
IVF
$6.47M
$20.1K ﹤0.01%
+26,722
IOBT icon
248
IO Biotech
IOBT
$23.7M
$15.2K ﹤0.01%
+24,964
CHRS icon
249
Coherus Oncology
CHRS
$247M
$14.7K ﹤0.01%
10,366
MTSR
250
DELISTED
Metsera Inc
MTSR
-152,521